Found a bug or want a feature? Verified reports earn free credits.
Log inSign up
Back to alerts
LORDSCHLONSELords Chloro Alkali Limited· Chemicals & PetrochemicalsHighNeutral
Announced Mon, 9 Feb, 2026 · 18:46 IST

Q3 FY26 results: revenue up 71% YoY, PAT jumps 264%; Rs 42.7 Cr equity allotted

Revenue Growth 20pctPat Growth 25pctRelated Party TransactionsResults View source PDFExplain this filing

LORDSCHLO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-5.9%Reaction day
₹154.08
prior close
₹155.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.0%-6.9% vs market
Commodity Chemicals peers, median of 53sector+0.3%-6.2% vs sector

On the reaction day the stock moved 6.9 pts less than Nifty Microcap 250 and 6.2 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-3.9
10m
-4.2
15m
-4.2
30m
-5.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-5.9+1.0-6.9+0.3-6.2
Next day
-8.6+0.5-9.1-0.3-8.3
2d
-10.1-0.0-10.1-0.4-9.8
3d
-8.2-1.5-6.8-1.6-6.7
4d
-12.4-2.2-10.2-2.7-9.7
5d
-15.8-1.2-14.5-3.0-12.7
1w
-18.1-2.4-15.8-3.5-14.6
15d
-19.3-8.8-10.5-7.6-11.7
1m
-20.2-8.3-11.9-9.4-10.7
2m
-0.1-3.5+3.5-5.9+5.8
3m
-5.5+6.4-11.9+2.5-8.0
UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 53Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q3 FY26 results (Dec 2025). Revenue from operations rose 71% YoY to Rs 93.95 Cr; for 9M FY26, revenue grew 54% to Rs 292.49 Cr and PAT jumped over 6x to Rs 24.10 Cr. Allotted 35 lakh equity shares at Rs 122 on warrant conversion, raising Rs 42.70 Cr (mainly to promoters). MD Ajay Virmani reappointed for 5 years from July 2026.

Likely market impact

Strong Q3 with revenue up 71% YoY, PAT over 6x; modest dilution from Rs 42.7 Cr warrant conversion.